Why Most MedTech AI Pilots Never Reach Production

Most MedTech AI pilots do not fail because of the model.

They fail because the organization was never operationally ready to scale them.

That pattern is becoming increasingly clear across the enterprise AI market:
• RAND Corporation estimates that more than 80% of AI projects fail to deliver business value
• Gartner reports that only 48% of AI projects make it into production
• MIT research found that 95% of generative AI pilots produce no measurable P&L impact, often due to workflow and integration issues rather than model performance

The pilot works in a controlled environment:
• curated data
• dedicated resources
• executive attention

Production is different.

That’s where AI collides with fragmented data, disconnected workflows, unclear ownership, regulatory constraints, and low frontline adoption.

At N28 Technologies, we’ve seen the same pattern repeatedly: organizations invest heavily in AI capability while underinvesting in the operational foundation required to support it.

That’s the real scaling problem.

1. AI-Ready Data Is Still Rare

Most MedTech organizations have data. Few have operationally usable data.

Clinical systems, CRM platforms, service data, device telemetry, and commercial operations often live in disconnected environments with inconsistent identifiers and fragmented governance.

This is becoming one of the biggest enterprise AI bottlenecks. Gartner has repeatedly identified poor data quality and weak governance as leading causes of AI project failure.

A pilot can work around this with curated datasets. Production cannot.

At N28 Technologies, we consistently see AI success tied directly to the quality of the operational data layer underneath it.

AI scales the quality of your data foundation — good or bad.

2. AI Pilots Ignore Workflow Reality

Many AI pilots fail because they are designed outside the operational systems people use every day.

Standalone dashboards and disconnected interfaces may work in a pilot environment, but they rarely drive long-term adoption.

MIT research on enterprise GenAI deployments found that flawed integration into existing workflows was one of the primary reasons AI projects failed to generate measurable business impact.

If AI recommendations are not embedded directly into the workflows teams already trust, usage drops quickly.

For MedTech organizations, that means AI must connect directly into systems like Salesforce, Health Cloud, Service workflows, and commercial operations platforms.

The organizations scaling AI successfully are designing around workflow execution, not model experimentation.

3. Governance and Ownership Arrive Too Late

MedTech organizations often treat governance as a post-pilot exercise when it should shape the architecture from day one.

This challenge is becoming more acute as AI regulation expands across healthcare, medical devices, and enterprise software. Gartner recently projected that more than 40% of agentic AI projects could be abandoned due to rising costs, governance gaps, and unclear business value.

Regulatory review, auditability, model ownership, retraining processes, escalation paths, and compliance workflows all need to be part of the deployment strategy early.

Pilots usually have sponsors. Production systems require operational owners.

Without clear ownership, AI systems slowly lose trust, degrade operationally, and eventually disappear from frontline workflows.

4. Success Metrics Focus on Accuracy Instead of Operations

A 92% accurate model that nobody operationalizes is still a failed deployment.

Too many AI pilots optimize for technical performance while ignoring operational outcomes.

The organizations successfully scaling AI are measuring:
• reduced cycle times
• increased throughput
• faster service resolution
• improved workflow completion
• stronger user adoption

Not just model accuracy.

This shift matters because enterprise AI is increasingly moving from “insight generation” toward workflow execution.

AI only creates enterprise value when it changes operational execution.

The Real Question

Most MedTech organizations are asking:

“Where should we use AI?”
The better question is:
“What operational foundation does AI need in order to scale?”
Because scaling AI is not primarily a model problem.
It is a workflow, data, governance, and execution problem.
That is where successful deployments are won or lost.

At N28 Technologies, we believe the future of enterprise AI is not standalone models or disconnected copilots.
It is AI embedded directly into operational workflows where teams already execute work.
That requires more than technology.

It requires readiness.